Fixed Regimen Treatment in Unselected Naïve Patients Cohort with Neovascular Age-Related Macular Degeneration

Figure 3

Changes in BCVA (ETDRS letters) by age subgroup. (a) Patients ≤77 vs. >77 years. (b) Patients ≤80 vs. >80 years. (c) Patients ≤83 vs. >83 years. (d) Patients ≤85 vs. >85 years. Mean changes in BCVA after the loading dose (LD) and at the final follow-up were significant (). The eyes belonging to the older subgroups (>85 years old), although they presented significant (#) gains in the BCVA means after the LD, there were not significant differences at 12 months (12 mo). ns: not significant.

(a)

(b)

(c)

(d)